Thanks for the kind words chaps, it took us a full week to analyse and write this ~12,000 word beast!
Our goal was to paint the true value proposition up for grabs.
The biotech business is undervalued right now, as demonstrated at length in the report. The market totally writes off the dental business as a joke and isn't paying anything for it. And to think, while already undervalued, the market refuses to acknowledge likely future catalysts (discussed at length in the blog post) which could drive the share price to significantly higher prices.
One of the best opportunities we have ever seen on the ASX!
Enjoy the read folks!
To your first million,
-Trading For Millions
- Forums
- ASX - By Stock
- IHL
- Latest TFM update
Latest TFM update, page-3
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online